MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Magnetic resonance imaging(MRI)"

  • 2026 International Congress

    Deep Learning-Enhanced Multimodal MRI for Real-World Differentiation of Parkinsonian Disorders

    S. Hartono, H. Ulfah, Q. Sun, C. Liu, D. Patidar, P. Seow, P. Chai, Q. Lyu, R. Chen, E. Tan, L. Chan (Singapore, Singapore)

    Objective: To develop and evaluate an integrated, deep learning (DL)-enhanced multimodal MRI classification model combining nigrosome-1 (N1), neuromelanin (NM), free-water DTI (FW-DTI) and morphometry (MORPHO)…
  • 2026 International Congress

    Multimodal Imaging in Cervical Dystonia with Botulinum Toxin Treatment: A Pilot 5.0T MRI and 99mTc-MIBI SPECT/CT Study

    J. Li, L. Wang, X. Song, L. He, Y. Wang, J. Li, Y. Liu, S. Li, K. Li (Beijing, China)

    Objective: To comprehensively investigate structural, vascular, and metabolic alterations in cervical dystonia (CD) patients using ultra-high-field 5.0T magnetic resonance imaging (MRI) and 99mTc-MIBI SPECT/CT. Background:…
  • 2026 International Congress

    Cholinergic Pathway Degeneration Predicts Differential Phenoconversion to Synucleinopathies in Idiopathic REM Sleep Behavior Disorder

    D. Zhang, T. Wu (Beijing, China)

    Objective: This cross-sectional and longitudinal study aimed to elucidate the pattern of cholinergic white matter pathway degeneration underlying the phenoconversion trajectories in iRBD patients. Background:…
  • 2026 International Congress

    DTI-ALPS Insights into Glymphatic Dynamics and Neurovascular Changes in Parkinson’s Disease

    G. Yılmaz çakan, A. Bayram, B. Samancı, G. Kızılateş Evin, L. Karşıgil, G. Kenangil, A. Zırh, Y. Samancı (Istanbul, Turkey)

    Objective: To investigate glymphatic activity, structural small vessel disease (SVD) markers, and white matter microstructure in Parkinson’s disease (PD) patients, and to explore their associations…
  • 2026 International Congress

    Prospective Comparison of Volumetric and Diffusion MRI Biomarkers for Multiple System Atrophy

    F. Marchand, R. Viard, D. Devos, L. Defebvre, T. Ollivier, G. Kuchcinski, C. Moreau (Lille, France)

    Objective: We aimed to develop new imaging biomarkers allowing objective monitoring of early Multiple System Atrophy (MSA) progression, which could improve outcome definition for future…
  • 2026 International Congress

    Data-driven Longitudinal Trajectories of Hippocampal Volume in Parkinson’s Disease and Across the Neurodegenerative Disease Spectrum

    U. Saeed, S. E Black, C. Marras, M. A Binns, D. P Breen, K. N Fishman, D. A Grimes, B. Levine, P. M Mclaughlin, A. K Troyer, R. Bartha, H. Zetterberg, A. E Lang, M. Masellis (Toronto, Canada)

    Objective: To elucidate hippocampal (HP) volume trajectories in Parkinson disease (PD) and across the neurodegenerative disease (NDD) spectrum. Background: HP volume is a critical neuroimaging…
  • 2026 International Congress

    Diagnostic Odyssey in L-2-Hydroxyglutaric Aciduria: A Case with Progressive Cerebellar and Extrapyramidal Movement Disorder

    A. Saini, S. Mehta (chandigarh, India)

    Objective: To highlight the evolution of movement disorder phenotype and diagnostic challenges in a child with L-2-hydroxyglutaric aciduria (L2HGA). Background: L2HGA is a rare autosomal-recessive…
  • 2026 International Congress

    Neuromelanin-Sensitive MRI as a Marker of Clinical Severity and Disease Burden in Parkinson’s Disease

    R. Akande, T. Kustermann, S. Holiga, J. Anzures-Cabrera, G. Pagano (Basel, Switzerland)

    Objective: To quantify associations between neuromelanin-sensitive MRI (NM-MRI) metrics and clinical severity and cumulative disease burden markers in Parkinson’s disease (PD). Background: NM-MRI visualises neuromelanin-containing…
  • 2026 International Congress

    Spatiotemporal Trajectories of Plasma Biomarkers and Diffusion MRI Metrics in Parkinson’s Disease

    S. Ueno, H. Takeshige-Amano, S. Miyaguchi, K. Takabayashi, Y. Yada, Y. Kondo, D. Samayoa, E. Igami, T. Ogawa, S. Ueno, W. Sako, T. Tateishi, T. Hoshino, K. Kamagata, N. Hattori, N. Honda, T. Hatano (Tokyo, Japan)

    Objective: To investigate the spatiotemporal dynamics of multimodal biomarkers and their role in early prediction of cognitive decline. Background: Cognitive impairment is a major source…
  • 2026 International Congress

    Dynamic and Multimodal Prediction of Phenoconversion to Cerebellar Multiple Sytem Atrophy among Sporadic Late-Onset Cerebellar Ataxia

    T. Wirth, A. Storck, T. Bogdan, I. Pei, IJ. Namer, S. Kremer, C. Tranchant, M. Anheim (Strasbourg, France)

    Objective: To dynamically predict phenoconversion from a sporadic late-onset cerebellar ataxia (SLOCA) phenotype to MSA-C. Background: Cerebellar multiple system atrophy (MSA-C) is diagnosed according to…
  • 1
  • 2
  • 3
  • …
  • 88
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley